We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Chemo Plus Immunotherapy Shows Promise As First-line Treatment for Mesothelioma

News   Jun 12, 2020 | Original story from Johns Hopkins

 
Chemo Plus Immunotherapy Shows Promise As First-line Treatment for Mesothelioma

A spheroid of mesothelioma tumor cells used to study the deadly form of lung cancer in the laboratory. Credit: National Cancer Institute, National Institutes of Health

 
 
Advertisement
 

RELATED ARTICLES

Creating an Artificial Energy Source To Power Muscles

News

A new study in the Biophysical Journal outlines the work of scientists who have created a series of compounds that could serve as an alternative synthetic energy source for myosin.

READ MORE

Protein Found in Pickled Capers Important for Brain and Heart Health

News

A compound commonly found in pickled capers has been shown to activate proteins required for normal human brain and heart activity, and may even lead to future therapies for the treatment of epilepsy and abnormal heart rhythms.

READ MORE

Ketamine for Depression Still Too Expensive for Widespread Use

News

A cost-benefit analysis study has determined that esketamine, a nasal spray used to treat severe depression, is currently too expensive for widespread use.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE